International Edition
Latest News
Business

KKR to Buy Integer Holdings for $4.3 Billion

Private equity firm Kkr & Co. is nearing a deal to acquire medical device manufacturer Integer Holdings Corp. for approximately $4.3 billion in cash, according to reports by The Wall Street Journal. The transaction would rank among the…

KKR to Buy Integer Holdings for $4.3 Billion

Private equity firm Kkr & Co. is nearing a deal to acquire medical device manufacturer Integer Holdings Corp. for approximately $4.3 billion in cash, according to reports by The Wall Street Journal. The transaction would rank among the largest private equity acquisitions in the healthcare technology sector in recent months, marking a significant consolidation move as buyout firms target specialized manufacturing assets.

Transaction Details and Valuation

According to The Wall Street Journal, negotiations between KKR and Integer Holdings are in advanced stages, with a definitive agreement expected soon barring any last-minute complications. The proposed all-cash deal values Integer at roughly $4.3 billion, reflecting strong private equity appetite for companies that supply components and outsourced manufacturing to major medical technology corporations. Integer, based in Plano, Texas, produces cardiac rhythm management devices, neuromodulation systems, and surgical components used by global healthcare giants.

Strategic Impact on the Medical Device Market

The potential buyout highlights a broader trend of private equity deployment into resilient healthcare supply chains. Integer operates as one of the largest medical device outsource manufacturers in the world, serving customers who increasingly rely on third-party specialists to manage complex regulatory requirements and production scaling. By taking the company private, KKR would position itself to fund Integer’s long-term capital projects and expansion initiatives away from the immediate pressures of public market quarterly earnings reports.

Market Reaction and Regulatory Path

Shares of Integer Holdings experienced upward movement in pre-market trading following The Wall Street Journal’s reporting on the exclusive talks. Financial advisors and legal teams for both KKR and Integer are currently finalizing merger documentation. Formal announcement of the transaction remains subject to final board approvals and standard regulatory clearances from antitrust authorities, though industry analysts anticipate a smooth review process given the supplier nature of Integer’s business model.

Frequently Asked Questions

Who is acquiring Integer Holdings?

Private equity firm KKR is nearing a deal to acquire Integer Holdings, according to reports by The Wall Street Journal.

What is the reported value of the deal?

The proposed transaction values Integer Holdings at approximately $4.3 billion in cash.

What does Integer Holdings manufacture?

Integer Holdings produces specialized medical device components, including cardiac rhythm management devices and neuromodulation systems, operating primarily as an outsource manufacturer for the healthcare industry.

ITGR Stock Analysis: Is Integer Holdings STILL A Buy At $121?
About the author: Marcus Liu - Business Editor

MBA and ex‑B bureau chief specializing in global finance and fintech. Marcus speaks Mandarin, Japanese, and English, and has interviewed CEOs from the Fortune 50 to Y‑Combinator unicorns. Marcus Liu delivers sharp analysis on markets, startups, and corporate strategy for investors and entrepreneurs alike.